New medicine
Exciting! There are many new medicines being developed and approved every year. Here are some recent examples:
- Paxlovid (nirmatrelvir and ritonavir): A COVID-19 treatment pill developed by Pfizer, which has shown to reduce hospitalization and death rates in high-risk patients.
- Aduhelm (aducanumab): A new Alzheimer's disease treatment developed by Biogen, which is the first FDA-approved treatment to target amyloid beta, a protein associated with the disease.
- Vaxzevria (AstraZeneca's COVID-19 vaccine): A COVID-19 vaccine developed by AstraZeneca, which has been approved for emergency use in many countries.
- Lumakras (sotorasib): A targeted therapy for non-small cell lung cancer (NSCLC) developed by Pfizer, which has shown to improve overall survival rates.
- Zynquista (sotagliflozin): A new oral medication for type 1 diabetes developed by Sanofi and Eli Lilly, which has shown to improve blood sugar control and reduce the risk of severe hypoglycemia.
- Brexafemme (brexanolone): A new treatment for postpartum depression developed by Sage Therapeutics, which has shown to improve symptoms of depression in women.
- Talzenna (talazoparib): A targeted therapy for breast cancer developed by Pfizer, which has shown to improve overall survival rates in patients with advanced breast cancer.
- Vonjo (pacritinib): A new treatment for myelofibrosis developed by CTI Biopharma, which has shown to improve symptoms and quality of life in patients with the disease.
- Cassikima (fam-trastuzumab deruxtecan-nxki): A new treatment for HER2-positive breast cancer developed by Daiichi Sankyo, which has shown to improve overall survival rates.
- Zepzelca (nelipepimut-S): A new treatment for small cell lung cancer developed by Immune Pharmaceuticals, which has shown to improve overall survival rates.
These are just a few examples of the many new medicines being developed and approved every year.